ERMN and COVID-19: The World Health Organization released a statement on the antigen composition of COVID-19 vaccines in April 2024, in which the adaptation of future COVID-19 vaccines to the spike protein of JN.1, a closely related subvariant of BA.2.86, is recommended [34].